In vivo screen of Plasmodium targets for mosquito-based malaria control.

Saved in:
Bibliographic Details
Title: In vivo screen of Plasmodium targets for mosquito-based malaria control.
Authors: Probst AS; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Paton DG; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Infectious Disease, University of Georgia, Athens, GA, USA., Appetecchia F; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Bopp S; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Adams KL; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Rinvee TA; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Pou S; VA Medical Center, Portland, OR, USA., Winter R; VA Medical Center, Portland, OR, USA., Du EW; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Yahiya S; Department of Life Sciences, Imperial College London, London, UK., Vidoudez C; Harvard Center for Mass Spectrometry, Cambridge, MA, USA., Singh N; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Rodrigues J; Global Health Medicines R&D, GlaxoSmithKline, Madrid, Spain., Castañeda-Casado P; Global Health Medicines R&D, GlaxoSmithKline, Madrid, Spain., Tammaro C; Department of Chemistry and Pharmaceutical Technologies, Sapienza University of Rome, Rome, Italy., Chen D; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA., Godinez-Macias KP; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA., Jaramillo JL; Southwest Research Institute, San Antonio, TX, USA., Poce G; Department of Chemistry and Pharmaceutical Technologies, Sapienza University of Rome, Rome, Italy., Rubal MJ; Southwest Research Institute, San Antonio, TX, USA., Nilsen A; VA Medical Center, Portland, OR, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA., Winzeler EA; Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA., Baum J; Department of Life Sciences, Imperial College London, London, UK.; School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia., Burrows JN; Medicines for Malaria Venture, Geneva, Switzerland., Riscoe MK; VA Medical Center, Portland, OR, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA., Wirth DF; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA. dfwirth@hsph.harvard.edu.; Infectious Disease and Microbiome Program, The Broad Institute, Cambridge, MA, USA. dfwirth@hsph.harvard.edu., Catteruccia F; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA. fcatter@hsph.harvard.edu.; Howard Hughes Medical Institute, Boston, MA, USA. fcatter@hsph.harvard.edu.
Source: Nature [Nature] 2025 Jul; Vol. 643 (8072), pp. 785-793. Date of Electronic Publication: 2025 May 21.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-025-09039-2